JIM LUYENDYK

Mechanisms linking the hemostatic system to liver injury

May 22, 2020

Jim received his bachelor’s degree in biochemistry from Colorado State University and his PhD in Pharmacology and Toxicology from Michigan State University, after which he conducted post-doctoral studies at The Scripps Research Institute. Prior to joining the faculty at Michigan State University in 2012, he was a faculty member of the Department of Pharmacology, Toxicology and Therapeutics at University of Kansas Medical Center for 5 years. Dr. Luyendyk has published more than 100 peer-reviewed research articles and reviews in the areas of liver disease and toxicity. His current research focuses on processes whereby the coagulation cascade is activated by hepatic injury and the mechanisms linking components of the hemostatic system to the pathogenesis of liver toxicity and repair. He is a member of the editorial board of Toxicological Sciences and Journal of Thrombosis and Haemostasis and is the 2020-2021 Chair of the NIH XNDA Study Section. Dr. Luyendyk has been an active member of the Society of Toxicology for 20 years, having served in numerous leadership positions, and most recently completed his term as Chairperson of the Committee on Diversity Initiatives.